Gerresheimer Q4 Earnings Call Highlights

Interested in Gerresheimer AG? Here are five stocks we like better.

Gerresheimer said it has completed its compliance and accounting review, received an unqualified audit opinion for 2025, and is now focused on two priorities: selling Centor and refinancing debt.

The company's restatement hit 2024 results more than previously estimated, cutting revenue by €45 million and EBITDA by €31 million, while it also booked €258 million in impairments tied mainly to development projects and the Chicago plant.

2025 revenue rose to €2.3 billion on the Bormioli Pharma acquisition, but organic growth was nearly flat and primary packaging glass remained weak; Gerresheimer forecast 2026 revenue in the lower half of its range and negative free cash flow before M&A.

Gerresheimer (ETR:GXI) said it has completed a broad review of compliance and accounting matters, published its audited 2025 annual report and is now focused on selling Centor, refinancing debt and improving cash generation.

Chief Executive Officer Uwe Röhrhoff, who returned to the company in November, said the new management board's focus "right from day one" has been on governance, cleanup and transformation. He said investigation

Fuente original: Yahoo Finance (https://finance.yahoo.com/markets/stocks/articles/gerresheimer-q4-earnings-call-highlights-150221570.html)